Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Formoterol Fumarate Powder for Inhalation

Approval Number

国药准字HJ20130379

CompanyASTRAZENECA AB

Registration Date

December 28, 2022

Previous Approval Numbers

H20130379

Drug Information

Generic Name

富马酸福莫特罗吸入粉雾剂

Trade Name

奥克斯都保

Dosage Form

吸入粉雾剂

Strength

每吸9.0μg，60吸/支

Drug Type

化学药品

Registration Date

December 28, 2022

Expiry Date

December 27, 2027

Company Information

Applicant Company

Company NameASTRAZENECA AB

Company Address

SE-151 85 Södertälje, Sweden

Manufacturing Company

Company NameASTRAZENECA AB

Company Address

Forskargatan 18, SE-151 36 Södertälje, Sweden

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy